203 related articles for article (PubMed ID: 28248600)
1. Mitochondria-Targeted Antioxidant Mitoquinone Reduces Cisplatin-Induced Ototoxicity in Guinea Pigs.
Tate AD; Antonelli PJ; Hannabass KR; Dirain CO
Otolaryngol Head Neck Surg; 2017 Mar; 156(3):543-548. PubMed ID: 28248600
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Mitoquinone for Protecting Against Amikacin-Induced Ototoxicity in Guinea Pigs.
Dirain CO; Ng MRAV; Milne-Davies B; Joseph JK; Antonelli PJ
Otol Neurotol; 2018 Jan; 39(1):111-118. PubMed ID: 29194212
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted antioxidant MitoQ reduces gentamicin-induced ototoxicity.
Ojano-Dirain CP; Antonelli PJ; Le Prell CG
Otol Neurotol; 2014 Mar; 35(3):533-9. PubMed ID: 24518411
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of apoptotic markers in HEI-OC1 cells treated with gentamicin with and without the mitochondria-targeted antioxidant mitoquinone.
Jadidian A; Antonelli PJ; Ojano-Dirain CP
Otol Neurotol; 2015 Mar; 36(3):526-30. PubMed ID: 25076226
[TBL] [Abstract][Full Text] [Related]
5. Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone.
Ojano-Dirain CP; Antonelli PJ
Laryngoscope; 2012 Nov; 122(11):2543-8. PubMed ID: 22965463
[TBL] [Abstract][Full Text] [Related]
6. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
[TBL] [Abstract][Full Text] [Related]
7. Astragalosides reduce cisplatin ototoxicity in guinea pigs.
Xiong M; He Q; Wang J; Lai H
ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):131-6. PubMed ID: 21494054
[TBL] [Abstract][Full Text] [Related]
8. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
[TBL] [Abstract][Full Text] [Related]
9. Assessment of mitochondrial membrane potential in HEI-OC1 and LLC-PK1 cells treated with gentamicin and mitoquinone.
Ng MR; Antonelli PJ; Joseph J; Dirain CO
Otolaryngol Head Neck Surg; 2015 Apr; 152(4):729-33. PubMed ID: 25550222
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
11. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
12. End points for cisplatin ototoxicity.
Qureshy K; Blakley B; Alsaleh S; Quddusi T; Berard S
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S45-8. PubMed ID: 21453661
[TBL] [Abstract][Full Text] [Related]
13. Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?
Saliba I; El Fata F
Neurotox Res; 2012 Apr; 21(3):302-8. PubMed ID: 21989624
[TBL] [Abstract][Full Text] [Related]
14. The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against cisplatin ototoxicity.
Yassuda CC; Righetti AE; Cury MC; Hyppolito MA; Oliveira JA; Féres O
Acta Cir Bras; 2008; 23 Suppl 1():72-6; discussion 76. PubMed ID: 18516452
[TBL] [Abstract][Full Text] [Related]
15. The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity.
Kasse CA; Cruz OLM; Iha LCN; Costa HO; Lopes EC; Coelho F
Braz J Otorhinolaryngol; 2008; 74(5):712-717. PubMed ID: 19082353
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E reduces cisplatin ototoxicity.
Kalkanis JG; Whitworth C; Rybak LP
Laryngoscope; 2004 Mar; 114(3):538-42. PubMed ID: 15091231
[TBL] [Abstract][Full Text] [Related]
17. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the protective effect of α-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study.
Ozkul Y; Songu M; Basoglu MS; Ozturkcan S; Katilmis H
J Craniofac Surg; 2014 Jul; 25(4):1515-8. PubMed ID: 24905944
[TBL] [Abstract][Full Text] [Related]
20. A clinically derived guinea pig dosing model of cisplatin ototoxicity.
Stanford JK; Bosworth NA; Morgan DS; Chen T; Spankovich C
Hear Res; 2021 May; 404():108202. PubMed ID: 33621791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
